Safety and Efficacy of Acarbose+Saxagliptin Compared With Metformin+Saxagliptin in Patients With Type 2 Diabetes
A Randomized, Non-inferiority, Open-label Clinical Trial to Evaluate the Safety and Efficacy of GAcarbose+Saxagliptin Compared With Metformin+Saxagliptin in Patients With Type 2 Diabetes in Chinese
Sponsor: Fifth Affiliated Hospital, Sun Yat-Sen University
Listed as NCT02605772, this PHASE4 trial focuses on Type 2 Diabetes Mellitus and remains ongoing. Sponsored by Fifth Affiliated Hospital, Sun Yat-Sen University, it has been updated 7 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE4
-
Feb 2018 — Jun 2018 [monthly]
Unknown Status PHASE4
Status: Not Yet Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Feb 2017 — Feb 2018 [monthly]
Not Yet Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE4
First recorded
Dec 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fifth Affiliated Hospital, Sun Yat-Sen University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.